Monographie - Alfentanil hydrochloride

Ostatnia aktualizacja :
19/11/2024

Alfentanil hydrochloride

Struktura chemiczna

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfenta	Iran, Peru, Stany Zjednoczone Ameryki
Alfentanil	Chile, Iran, Kanada, KolumbiaKolumbia, Niemcy, Stany Zjednoczone Ameryki, Wielka Brytania
Alfiject	Iran
Limifen	Hiszpania
Rapifen	Arabia Saudyjska, Australia, Austria, Belgia, Chile, Dania, Finlandia, Francja , Grecja, Holandia, Irlandia, Luksemburg, Malezja, Niemcy, Norwegia, nowa Zelandia, Polska, Portugalia, Szwajcaria, Szwecja, Tunisie, Węgry, Wielka Brytania

Bibliografia : Alfentanil hydrochloride

	typ	publikacja
59	Czasopismo	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
299	Czasopismo	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300	Czasopismo	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319	Czasopismo	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
660	Czasopismo	Michaels MR, Stauffer GL, Haas DP. Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Ann Pharmacotherapy 1996 ; 30: 228-232.
815	Czasopismo	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
921	Czasopismo	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1625	Czasopismo	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1712	Czasopismo	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1713	Czasopismo	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	Czasopismo	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	Czasopismo	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1861	Czasopismo	Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J. Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture. Int J Pharm 1996 ; 127: 255-259.
1925	Czasopismo	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
2086	Czasopismo	Sharley NA, Burgess NG. Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes. J Pharm Pract and Res 2003 ; 33: 279-281.
3380	Czasopismo	Eckle V-S, Heim E, Hahn M, Grasshoff C. Incompatibility of Piritramide with Cephalosporins. Ann Pharmacotherapy 2013 ;47:426-427.
3502	Laboratorium	Propofol (Diprivan®) - Summary of Products Characteristics Astra Zeneca 2012
3504	Laboratorium	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3601	Laboratorium	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012

Mentions Légales